Related Experiment Videos
Hyperaggregation effect in idiopathic thrombocytopenia and multiple transfused patients
Journal of Clinical Pathology
|September 1, 1973
Summary
This study shows that platelet aggregometry can detect platelet antibodies. Adding patient serum with antibodies to normal platelets potentiates aggregation, aiding in diagnosis.
Area of Science:
- Immunology
- Hematology
- Clinical Chemistry
Background:
- Platelet antibodies play a role in various immune thrombocytopenic disorders.
- Accurate detection of platelet antibodies is crucial for diagnosis and management.
- Existing methods for platelet antibody detection can be complex or lack sensitivity.
Purpose of the Study:
- To investigate a novel method for detecting platelet antibodies in vitro.
- To evaluate the utility of platelet aggregometry in identifying platelet-specific antibodies.
Main Methods:
- Serum from patients with suspected platelet antibodies was incubated with normal pooled platelet-rich plasma.
- Platelet aggregation was measured using a platelet aggregometer in response to agonists like adrenaline and adenosine diphosphate (ADP).
- The effect of an alpha-adrenergic blocking agent (tolazoline) on aggregation was assessed.
Main Results:
- Platelet aggregation was significantly enhanced when serum containing platelet antibodies was added.
- The addition of serum did not induce spontaneous platelet aggregation.
- Tolazoline reversed the primary aggregation wave induced by adrenaline, irrespective of serum presence.
Conclusions:
- Platelet aggregometry is a potentially useful tool for detecting platelet antibodies in vitro.
- Platelet antibodies likely potentiate platelet aggregation rather than causing direct agglutination in this assay.
- This method offers a sensitive approach to identify antibodies that affect platelet function.